Technology Commercialization Group (TCG)

What Technology Commercialization Group (TCG) does

Technology Commercialization Group (TCG) is a privately held, international business consulting firm founded in 1998 and headquartered in Raleigh, North Carolina (Research Triangle Park), with additional offices in San Diego, California and Heidelberg, Germany. The firm serves medical device, diagnostic, digital health, pharmaceutical, and biotechnology companies seeking to enter or expand within US, European, and Asian markets, with a particular emphasis on transatlantic market entry for European and Asian innovators.

TCG's service portfolio centers on three core practice areas: Building Markets (regulatory and reimbursement pathway assessment, distribution channel development, and go-to-market strategy), Strategic Connections (partner identification, licensing, M&A advisory, and investor matchmaking), and Creating Your Team (interim executive leadership, including CEO/COO/CFO roles, mentoring, and organizational build-out). The firm also operates the proprietary TCG MedTechLaunch Assessment Tool, a 17-point framework evaluating US market readiness across Product Value, Regulatory/Reimbursement, Market Adoption, and Business Model dimensions.

The business model is senior-partner-led professional services delivered through project-based and retainer engagements, primarily sourced via industry conference participation, white papers and case studies, LinkedIn presence, and an extensive transatlantic referral network. Pricing is quote-based and not publicly disclosed. The firm has completed hundreds of life science assignments since inception, with named engagements including the five-year US market entry build-out for TEM International's ROTEM delta hemostasis analyzer (establishing subsidiary TEM Systems, Inc.), interim BD leadership for Asklepios BioPharmaceutical yielding over a dozen licenses, advisory on the Chatham Therapeutics sale to Baxter for $70 million upfront, and licensing advisory to AveXis for SMA gene therapy technology.

Name

Technology Commercialization Group (TCG)

Legal name

Technology Commercialization Group, LLC

Website

https://tcgmedtech.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Raleigh

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Strategic Advisory and Consulting Services: TCG generates revenue through project-based consulting engagements providing strategic advisory services including market entry strategy, business development, regulatory and reimbursement pathway assessment, distribution channel development, and organizational effectiveness consulting. Services are delivered by senior partners on a project or retainer basis.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

TCG is a life sciences consulting firm that provides strategic advisory and interim management services to medical device, diagnostic, digital health, pharmaceutical, and biotechnology companies. Its services cover market entry strategy (particularly transatlantic US-Europe-Asia expansion), regulatory and reimbursement pathway assessment, distribution channel development, business development, licensing and M&A transactions, and executive team building. The firm delivers engagements through senior partner-led teams from offices in the Research Triangle Park (Raleigh, NC), San Diego, and Heidelberg, Germany.

Product overview

Technology Commercialization Group (TCG) is an international business consulting firm, not a software product company. TCG provides strategic advisory and interim management services to life science companies (medical device, diagnostic, digital health, pharmaceutical, and biotechnology) seeking market entry and growth. The core offerings include the TCG MedTechLaunch Assessment Tool (a 17-point evaluation framework), Strategic Advisory Services, Interim Management, Building Markets strategies, Strategic Connections (partner/investor identification), and Creating Your Team services. The TCG MedTechLaunch Assessment Tool is the primary structured product/module offering, used to evaluate product readiness across Product Value, Regulatory/Reimbursement, Market Adoption, and Business Model dimensions. White papers serve as knowledge resources supporting the advisory services.

Differentiator

Problem solved

Functional benefit

Brands

• TCG MedTechLaunch Assessment Tool: A 17-point assessment tool developed by TCG to evaluate the likelihood of success for new medtech products in the US market. The tool examines four key factors: Product Value, Regulatory and Reimbursement, Market Adoption, and Business Model.

Products and services

• TCG MedTechLaunch Assessment Tool A 17-point assessment tool that evaluates a medical device, digital health or health IT product's readiness for US market entry by examining four key factors: Product Value, Regulatory and Reimbursement, Market Adoption, and Business Model.
• Strategic Advisory Services Advisory services covering market entry, key opinion leader engagement, product launch, business development, reimbursement and regulatory pathway assessment, distribution channel development, and organizational effectiveness for life sciences companies.
• Interim Management Provides executive leadership including CEO, COO, and CFO roles for early-stage companies along with mentors and interim management solutions covering strategy, product development, geographic expansion, out-licensing, co-development, and fundraising advisory.
• Building Markets Strategies for new technologies and products to create rapid market acceptance, including navigation of cross-regional challenges when bringing products from one global region to another.
• Strategic Connections Connects clients with partners for product gap filling, company or asset acquisition or sale, and geographic expansion. Identifies investment partners from industry strategics to venture capital to angel funding.
• Creating Your Team Executive leadership services including selection of key positions, mentorship, and interim management for US, European and Asian life sciences companies.

Quantifiable outcome

• TCG has successfully completed hundreds of life science projects and assignments since 1998
• +2 more outcomes

Named customers7 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Four partnerships are on record, tiered core and minor.

• BioFilm Ltd.coreGTM or Marketing Partner · 5 August 2014TCG partnered with BioFilm, Ltd. (Glasgow, Scotland) to grow its North American business. BioFilm is a leading developer and contract manufacturer of Thin Dissolving Films (TDF) for OTC medicines, oral hygiene products, cosmetics and dietary supplements. TCG Partner Kathy Meserve leads BioFilm's North American Business Development.
• Life Science Consulting Network (LSCN)coreStrategic or Co-development Partner · 19 February 2013TCG and LSCN formed an international strategic partnership to help life science companies with transatlantic business development and corporate development projects. LSCN is a network of more than 20 partners and consulting companies based in Heidelberg, Germany. The partnership addresses the challenge that US and Europe are the two largest life science markets but have vastly different regulatory, reimbursement, marketing, and legal environments.
• TEM International GmbHcoreStrategic or Co-development PartnerTCG managed the complete US market entry for TEM International's ROTEM delta hemostasis analyzer over a five-year assignment. TCG established and developed TEM International's US subsidiary (TEM Systems, Inc.), hired and managed the national sales, marketing, distribution and customer service organization.
• MedTech InnovatorminorGTM or Marketing PartnerTCG collaborates with MedTech Innovator, the industry's nonprofit global competition and accelerator for medical device, digital health, and diagnostic companies, to highlight best-in-class start-ups at partnering events.

Scale indicators4 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Alacrita Consulting: Life sciences consulting firm offering strategic advisory, due diligence, and operational support to pharma and biotech. Comparable boutique model with senior-expert-led engagements.
• Locust Walk: Life sciences-focused transaction advisory firm providing strategic partnering, M&A, and capital raise services to biopharma and medtech. Closely comparable to TCG's Strategic Connections offering for biotech clients.
• Triangle Insights Group: Strategy consulting firm dedicated to the life sciences industry, with expertise in commercial strategy, launch planning, and market assessment for pharma, biotech, and medtech. Comparable in scope and boutique execution.
• Health Advances: Boutique life sciences strategy consulting firm specializing in commercial strategy, market entry, and transaction advisory for medtech, diagnostics, and biotech. Directly comparable in service offering, target clients, and boutique delivery model.
• Life Science Consulting Network (LSCN): Network of 20+ consulting partners based in Heidelberg, Germany, and TCG's formal strategic partner for transatlantic life science business development. Direct peer in transatlantic life sciences advisory.
• Back Bay Strategic Advisors: Boutique advisory firm for life sciences and technology companies with deep experience in market entry, licensing, and commercialization — directly overlapping TCG's core advisory and transatlantic mandate.

Broad incumbents

• ZS Associates: Large global management consulting firm with a major life sciences practice covering pharma, biotech, and medtech commercial strategy. Competes for similar mandates but at materially greater scale.
• McKinsey & Company (Life Sciences Practice): Global strategy consulting firm with a substantial healthcare and life sciences practice. Overlaps with TCG on pharma and medtech commercial strategy but operates at far larger scale with a leveraged consultant pyramid.
• Bain & Company (Healthcare Practice): Global strategy consulting firm with a deep healthcare and life sciences practice. Competes for the same commercial strategy and market entry mandates as TCG but at much larger scale and broader geographic footprint.
• Charles River Associates: Global consulting firm with a life sciences practice delivering strategic advisory, transaction support, and commercial strategy to pharma, biotech, and medtech — overlapping with TCG's biotech/medtech mandates at greater scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCHBxBLs7Qfp9kmOhwvkPfRw
• LinkedInlinkedin.com/company/technology-commercialization-group-tcg-

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Technology Commercialization Group (TCG)